Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biosynthesis of Lipids01:29

Biosynthesis of Lipids

114
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
114
Lipid Catabolism01:25

Lipid Catabolism

185
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
185
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

31.8K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.8K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

194
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
194
Amino Acid Catabolism01:18

Amino Acid Catabolism

222
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
222
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

127
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
127

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and Evaluation of Sulfobacin A and Analogues for Their Roles in Immunological Recognition.

ACS medicinal chemistry letters·2026
Same author

Lactobacillus iners at the nexus of microbiota, immunity, and pregnancy.

Journal of reproductive immunology·2026
Same author

Discovery of Sulfonamide Pantothenate Kinase Activators and Elucidation of the Role of Isoform Selectivity in Cellular Pantothenate Kinase Activation.

Journal of medicinal chemistry·2026
Same author

Mechanisms of 10-hydroxyoctadecanoic acid resistance in <i>Streptococcus pneumoniae</i>.

Journal of bacteriology·2025
Same author

Intracellular survival of <i>Staphylococcus aureus</i> in macrophages during osteomyelitis.

Virulence·2025
Same author

Mechanisms of 10-Hydroxyoctadecanoic acid resistance in <i>Streptococcus pneumoniae</i>.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Optimizing Hollow-Fiber Membranes for Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids
06:45

Author Spotlight: Optimizing Hollow-Fiber Membranes for Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids

Published on: August 9, 2024

1.4K

Mining Fatty Acid Biosynthesis for New Antimicrobials.

Christopher D Radka1, Charles O Rock1

  • 1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA; email: christopher.radka@stjude.org, charles.rock@stjude.org.

Annual Review of Microbiology
|June 1, 2022
PubMed
Summary

New antibiotic strategies targeting bacterial fatty acid synthesis (FASII) are crucial for combating resistance. Optimizing drug design against FASII can overcome resistance, aiding the development of novel antibacterial agents.

Keywords:
antibiotic resistanceantibioticsnatural productspathogen-specific antibioticstype II fatty acid synthesis

More Related Videos

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

9.8K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

10.0K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Optimizing Hollow-Fiber Membranes for Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids
06:45

Author Spotlight: Optimizing Hollow-Fiber Membranes for Continuous Liquid-Liquid Extraction of Medium-Chain Fatty Acids

Published on: August 9, 2024

1.4K
Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

9.8K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

10.0K

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biochemistry

Background:

  • Antibiotic resistance poses a significant global health threat, necessitating novel therapeutic agents.
  • Bacterial type II fatty acid synthesis (FASII) is essential for bacterial membrane integrity and vitamin production, representing a validated target for antibiotic development.

Purpose of the Study:

  • To explore the challenges and potential strategies for developing new antibiotics targeting bacterial FASII.
  • To address the limitations of broad-spectrum FASII inhibitors and the rapid development of resistance.

Main Methods:

  • Review of existing literature on FASII inhibitors and antibiotic resistance mechanisms.
  • Analysis of bacterial metabolic pathways, specifically fatty acid assimilation and FASII dependency.
  • Exploration of drug design principles to mitigate resistance mutations.

Main Results:

  • Broad-spectrum FASII inhibitors face challenges due to bacterial assimilation of exogenous fatty acids.
  • Pathogen-specific FASII inhibitors are a promising avenue, but rapid resistance via missense mutations is a major hurdle.
  • Early-stage drug design optimization can reduce the impact of on-target resistance mutations.

Conclusions:

  • Developing effective FASII-targeting antibiotics requires a shift towards pathogen-specific strategies.
  • Mitigating resistance through rational drug design is key to advancing FASII inhibitors.
  • A refocused approach to FASII inhibitor design can enhance the pipeline of new antibiotics to combat bacterial resistance.